Loading, please wait ...

News Analytics

sebi 1 1 2.
Market regulator Sebi has issued a warning letter to Aurobindo Pharma for disclosing “very limited and restricted information” to the stock exchanges about an USFDA audit of the company’s active pharmaceutical ingredients manufacturing facility (API) in Hyderabad. “The only fact disclosed was that a warning letter was received from the U.S. FDA.

The Angle

Subject Matter

  • Business, economics, society 77.92%
    • Companies, industries, organizations 100.00%
  • Government and social 22.08%
    • Legal, courts and investigations 100.00%

Emotional Reaction






Depth Chart

Here we provide depth for the multitude of dimensions lacing this article.

Connect your favorite information below with the lead sentence at the top of the page to build a mental model of the story.